← Eichor
Study identifier: NCT07154134 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome

Condition: Endocan · Copeptin · Serum  ·  Sponsor: Tanta University

PhaseN/A
Planned participants40
Who can joinAll sexes, 28 Weeks to 36 Weeks
Healthy volunteersNo

About this study

This work aims to investigate and compare the levels of serum endocan and serum copeptin on the first day of life and correlate their levels to the severity of respiratory distress in preterm neonates suffering from respiratory distress syndrome.

This description comes directly from the study's public registry record.

Talk to the study team

Asmaa M Elmesiry, MD  ·  00201224285567  ·  asmaa.elmesery@med.tanta.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Tanta UniversityTanta, El-Gharbia, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07154134